Teva announces successful upsizing and pricing of $2,300,000,000 (equivalent) senior notes; proceeds to repay existing debt

Tel aviv, israel, may 20, 2025 (globe newswire) -- teva pharmaceutical industries ltd. (nyse and tase: teva) (“teva”) announced today that it successfully upsized its offering and priced approximately $2,300,000,000 (equivalent) of its senior notes (the “notes”). the principal amount of the offering was increased from the previously announced offering size of $2,000,000,000 (equivalent). teva expects to use the net proceeds from the offerings (i) to fund the announced tender offers (collectively, the “tender offer”) to purchase, for cash, its 3.150% senior notes due 2026, 4.750% sustainability-linked senior notes due 2027, 3.750% sustainability-linked senior notes due 2027, 7.875% sustainability-linked senior notes due 2029, 7.375% sustainability-linked senior notes due 2029 and 8.125% sustainability-linked senior notes due 2031 (as it may be amended prior to expiration thereof), (ii) to pay fees and expenses in connection therewith and (iii) to the extent of any remaining proceeds, the repayment of outstanding debt upon maturity, tender offer or earlier redemption. net proceeds may be temporarily invested pending application for their stated purpose.
TEVA Ratings Summary
TEVA Quant Ranking